Hyderabad-based pharmaceutical company Dr Reddy’s Laboratories has forayed into the Rs 100-crore aesthetic dermatology market by forging a licensing and distribution agreement with Cosmederm Technologies, a US-based specialty pharmaceutical company focused on dermatology and aesthetic medicines.
The agreement grants Dr Reddy’s exclusive rights to distribute Cosmederm’s skincare products in India. Cosmederm’s proprietary technology allows for the formulation of highly potent, non-irritating skincare products in the areas of anti-aging, pruritus (itch) and others. The partnership is for two product lines – Refinity peel kits (glycolic acid 70 per cent) and Cosmederm peel kits (glycolic acid 50 per cent), the company stated in a release.
